TrialCancer prevention research (Philadelphia, Pa.)2014

Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.

Jean Y Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.